Similarly, a systematic review by Tsuboi et al. [33] confirmed the potential benefits of MAO-B inhibitors on selected NMS, such as depression, pain, and sleep disturbances, while emphasizing the scarcity of high-quality studies assessing their direct impact on fatigue. This evidence concerns the gene MAOB and depressive disorder.